Nuveen
TELO icon

Nuveen’s Telomir Pharmaceuticals TELO Stock Holding History

Nuveen’s Portfolio TELO Stock Details TELO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.74K Buy
+2,996
New +$3.52K ﹤0.01% 4738
2025
Q2 		– Sell
-24,990
Closed -$80.7K – 3434
2025
Q1 		$80.7K Hold
24,990
– – ﹤0.01% 3232
2024
Q4 		$103K Buy
+24,990
New +$118K ﹤0.01% 3288

Other funds holding TELO

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
PWM
Praetorian Wealth Management Carmel, California $582M AUM 12.38% 1-Year Est. Return
Morton Capital Management
Morton Capital Management Calabasas, California $828M AUM 13.29% 1-Year Est. Return
Clearstead Advisors
Clearstead Advisors Cleveland, Ohio $10.8B AUM 17.88% 1-Year Est. Return
Regions Financial Corp
Regions Financial Corp Birmingham, Alabama $16.4B AUM 18.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
GK Wealth Management
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Nuveen's TELO Position: Q3 2026 in Review

Nuveen opened a new position in Telomir Pharmaceuticals (TELO) in Q3 2026: 2,996 shares worth $3.74K. The stake represents ﹤0.01% of the portfolio and ranks #4738 among its holdings. This is a return to the name: Nuveen previously reported a position in TELO as recently as Q1 2025.

Nuveen first reported a position in TELO in Q4 2024 and has held it in 3 quarters since. The position peaked at $103K in Q4 2024. 10 funds tracked by Wall St. Rank hold TELO as of Q3 2026.

  • Nuveen held 2,996 shares of Telomir Pharmaceuticals worth $3.74K as of Q3 2026.
  • Telomir Pharmaceuticals was a new Nuveen position in Q3 2026.
  • Telomir Pharmaceuticals made up ﹤0.01% of Nuveen's portfolio in Q3 2026, its #4738 holding.
  • Nuveen first reported a position in Telomir Pharmaceuticals in Q4 2024 and has held it in 3 quarters since.
  • Nuveen's Telomir Pharmaceuticals position peaked at $103K in Q4 2024.
  • 10 funds tracked by Wall St. Rank held Telomir Pharmaceuticals as of Q3 2026.

Based on Nuveen's 13F filing for Q3 2026, filed 10 Nov 2026.